Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-04-01 Sale |
2021-04-05 7:04 pm |
PMV Pharmaceuticals Inc. | PMVP | Schroeder Thilo Director |
60,628 | $33.63 | $2,038,792 | 2,272,903 (Indirect) |
View |
| 2021-03-29 Sale |
2021-03-31 9:25 pm |
PMV Pharmaceuticals Inc. | PMVP | Schroeder Thilo Director |
58,283 | $31.87 | $1,857,520 | 2,333,531 (Indirect) |
View |
| 2021-03-24 Sale |
2021-03-26 6:20 pm |
PMV Pharmaceuticals Inc. | PMVP | Schroeder Thilo Director |
136,476 | $34.03 | $4,644,130 | 2,391,814 (Indirect) |
View |
| 2020-09-25 Purchase(A) |
2020-10-02 6:42 pm |
PMV Pharmaceuticals Inc. | PMVP | ORONSKY ARNOLD L Director 10% Owner |
55,555 | $18 | $999,990 | 6,469,911 (Indirect) |
View |
| 2020-09-25 Purchase(A) |
2020-10-02 6:41 pm |
PMV Pharmaceuticals Inc. | PMVP | INTERWEST PARTNERS X LP InterWest Management Partners X LLC NASR KHALED Desai Keval Kliman Gilbert H 10% Owner |
55,555 | $18 | $999,990 | 6,469,911 (Direct) |
View |
| 2020-09-25 Purchase |
2020-09-29 4:40 pm |
PMV Pharmaceuticals Inc. | PMVP | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. Former 10% Owner |
950,000 | $18 | $17,100,000 | 2,329,073 (Indirect Direct) |
View |
| 2020-09-25 Purchase |
2020-09-29 4:39 pm |
PMV Pharmaceuticals Inc. | PMVP | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner |
950,000 | $18 | $17,100,000 | 475,000 (Indirect) |
View |
| 2020-09-25 Purchase |
2020-09-29 4:38 pm |
PMV Pharmaceuticals Inc. | PMVP | Thompson Peter A. Director 10% Owner |
950,000 | $18 | $17,100,000 | 475,000 (Indirect) |
View |
| 2020-09-25 Purchase |
2020-09-29 4:33 pm |
PMV Pharmaceuticals Inc. | PMVP | ORONSKY ARNOLD L Director 10% Owner |
55,000 | $18 | $990,000 | 6,469,356 (Indirect) |
View |
| 2020-09-29 Purchase |
2020-09-29 4:30 pm |
PMV Pharmaceuticals Inc. | PMVP | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
950,000 | $18 | $17,100,000 | 1,710,265 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-04-05 Option Award |
2021-04-07 4:28 pm |
N/A 2031-04-05 |
PMV Pharmaceuticals Inc. | PMVP | BAUM CHARLES M Director |
32,677 | $0 | 32,677 (Direct) |
View |
| 2021-03-24 Other |
2021-03-25 7:34 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | INTERWEST PARTNERS X LP InterWest Management Partners X LLC NASR KHALED Desai Keval Kliman Gilbert H 10% Owner |
1,012,892 | $0 | 6,495,072 (Direct) |
View |
| 2020-12-08 Exercise |
2020-12-31 4:25 pm |
N/A 2028-02-21 |
PMV Pharmaceuticals Inc. | PMVP | Kung Winston COO, CFO |
1,600 | $0 | 476,046 (Direct) |
View |
| 2020-12-08 Exercise |
2020-12-31 4:25 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Kung Winston COO, CFO |
1,600 | $3.22 | 476,046 (Direct) |
View |
| 2020-11-18 Exercise |
2020-11-20 4:12 pm |
N/A 2025-05-11 |
PMV Pharmaceuticals Inc. | PMVP | Mack David Henry President and CEO |
2,470 | $0 | 780,230 (Direct) |
View |
| 2020-11-18 Exercise |
2020-11-20 4:12 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Mack David Henry President and CEO |
2,470 | $0.53 | 780,230 (Direct) |
View |
| 2020-11-11 Option Award |
2020-11-12 4:14 pm |
N/A 2030-06-22 |
PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director |
45,332 | $0 | 45,332 (Direct) |
View |
| 2020-09-29 Conversion(A) |
2020-10-02 6:42 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | ORONSKY ARNOLD L Director 10% Owner |
6,414,356 | $0 | 6,469,911 (Indirect) |
View |
| 2020-09-29 Conversion(A) |
2020-10-02 6:41 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | INTERWEST PARTNERS X LP InterWest Management Partners X LLC NASR KHALED Desai Keval Kliman Gilbert H 10% Owner |
6,414,356 | $0 | 6,469,911 (Direct) |
View |
| 2020-09-29 Conversion |
2020-09-29 4:49 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Nextech V Oncology S.C.S. SICAV-SIF NEXTECH V GP S.A R.L. Bleyer Dalia Lips Thomas Detournay Philippe Former 10% Owner |
2,528,290 | $0 | 2,528,290 (Direct) |
View |
| 2020-09-29 Conversion |
2020-09-29 4:48 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Former 10% Owner |
760,267 | $0 | 760,267 (Direct) |
View |
| 2020-09-29 Conversion |
2020-09-29 4:47 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Euclidean Capital LLC Greenland A LLC Greenland FP LLC Greenland NFP B Ltd. Greenland NFP LLC Simons Marilyn Chhabra Ashvin SIMONS JAMES H Former 10% Owner |
4,179,416 | $0 | 132,601 (Indirect) |
View |
| 2020-09-29 Conversion |
2020-09-29 4:40 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. Former 10% Owner |
1,379,073 | $0 | 2,329,073 (Direct) |
View |
| 2020-09-29 Conversion |
2020-09-29 4:39 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner |
6,114,330 | $0 | 475,000 (Indirect) |
View |
| 2020-09-29 Conversion |
2020-09-29 4:38 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Thompson Peter A. Director 10% Owner |
6,114,330 | $0 | 475,000 (Indirect) |
View |
| 2020-09-29 Conversion |
2020-09-29 4:37 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Schroeder Thilo Director 10% Owner |
2,528,290 | $0 | 2,528,290 (Indirect) |
View |
| 2020-09-29 Conversion |
2020-09-29 4:35 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | INTERWEST PARTNERS X LP InterWest Management Partners X LLC NASR KHALED Desai Keval Kliman Gilbert H 10% Owner |
6,414,356 | $0 | 6,469,356 (Direct) |
View |
| 2020-09-29 Conversion |
2020-09-29 4:33 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | ORONSKY ARNOLD L Director 10% Owner |
6,414,356 | $0 | 6,469,356 (Indirect) |
View |
Ownership(A) |
2020-09-29 4:31 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Nextech V Oncology S.C.S. SICAV-SIF NEXTECH V GP S.A R.L. Bleyer Dalia Lips Thomas Detournay Philippe 10% Owner |
0 | $0 | 2,528,290 (Direct) |
View |
| 2020-09-29 Conversion |
2020-09-29 4:30 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
760,265 | $0 | 1,710,265 (Indirect) |
View |
Ownership |
2020-09-24 7:36 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
0 | $0 | 760,265 (Indirect) |
View |
Ownership |
2020-09-24 7:35 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Former 10% Owner |
0 | $0 | 760,267 (Direct) |
View |
Ownership |
2020-09-24 7:34 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Nextech V Oncology S.C.S. SICAV-SIF 10% Owner |
0 | $0 | 2,528,290 (Direct) |
View |
Ownership |
2020-09-24 7:33 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | INTERWEST PARTNERS X LP InterWest Management Partners X LLC NASR KHALED Desai Keval Kliman Gilbert H 10% Owner |
0 | $0 | 6,414,356 (Direct) |
View |
Ownership |
2020-09-24 7:31 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Euclidean Capital LLC Greenland A LLC Greenland FP LLC Greenland NFP B Ltd. Greenland NFP LLC Simons Marilyn Chhabra Ashvin SIMONS JAMES H 10% Owner |
0 | $0 | 4,179,416 (Indirect) |
View |
Ownership |
2020-09-24 7:29 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Double Epiphany LLC 10% Owner |
0 | $0 | 1,282,026 (Direct) |
View |
Ownership |
2020-09-24 7:27 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Levine Alison 10% Owner |
0 | $0 | 427,342 (Direct) |
View |
Ownership |
2020-09-24 7:26 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Dawson Samantha 10% Owner |
0 | $0 | 427,342 (Direct) |
View |
Ownership |
2020-09-24 7:24 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. 10% Owner |
0 | $0 | 1,379,073 (Direct) |
View |
Ownership |
2020-09-24 7:23 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC Director 10% Owner |
0 | $0 | 6,114,330 (Indirect) |
View |
Ownership |
2020-09-24 7:21 pm |
N/A 2030-08-11 |
PMV Pharmaceuticals Inc. | PMVP | Stelzer Laurie Director |
0 | $0 | 32,667 (Direct) |
View |
Ownership |
2020-09-24 7:20 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Schroeder Thilo Director 10% Owner |
0 | $0 | 2,528,290 (Indirect) |
View |
Ownership |
2020-09-24 7:17 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Thompson Peter A. Director 10% Owner |
0 | $0 | 6,114,330 (Indirect) |
View |
Ownership |
2020-09-24 7:16 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | ORONSKY ARNOLD L Director 10% Owner |
0 | $0 | 6,414,356 (Indirect) |
View |
Ownership |
2020-09-24 7:15 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | LEVINE ARNOLD J Director |
0 | $0 | 427,342 (Direct) |
View |